A prospective observational study of the efficacy and safety of CPT-11 based regimens (CPT-11+platinum analogues) for UGT1A1 genotype guided patients
Not Applicable
- Conditions
- Small cell lung cancer, non-small cell lung cancer, cervical cancer, ovarian cancer and gastric cancer (inoperable or recurrent)
- Registration Number
- JPRN-jRCT1080220914
- Lead Sponsor
- DAIICHI SANKYO COMPANY, LIMITED
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
1. Small cell lung cancer, non-small cell lung cancer, cervical cancer, ovarian cancer and gastric cancer
2. Patients to receiving CPT-11 plus platinum anolaogues regimens
Age requirement none
Exclusion Criteria
1. Contraindications of CPT-11
2. ECOG PS 3-4
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety<br>None
- Secondary Outcome Measures
Name Time Method Efficacy<br>None